Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact

Condition name Status OMIM number Documents
Conradi-Hunermann-Happle Syndrome approved 302960
Convulsions, Familial Infantile, with Paroxysmal Choreoathetosis, approved 602066
Cowden syndrome (CS)/PTEN Hamartoma Tumour Syndrome (PHTS) approved 601728, 158350, 153480, 605309
Craniofrontonasal syndrome (CFNS) approved 304110
Crigler-Najjar Syndrome Type 1 (CN1) approved 218800
Crouzon Syndrome approved 123500
Crouzon with acanthosis nigrans syndrome approved 612247
Currarino Syndrome approved 176450
Cystic Fibrosis (CF) approved 219700
Czech Dysplasia, metatarsal type also known as Progressive pseudorheumatoid dysplasia with hypoplastic toes approved 609162
Danon Disease approved 300257
D-bifunctional protein deficiency approved 261515
Dehydrated hereditary stomatocytosis approved 194380
Dentatorubral-Pallidoluysian Atrophy (DRPLA) approved 125370
Denys-Drash Syndrome (DDS) approved 194080
Desbuquois Dysplasia 1 (DBQD1) approved 251450
Diamond Blackfan Anaemia 1* approved 105650
Diarrhea 1, Secretory Chloride, Congenital (DIAR1) approved 214700
Diarrhea 10, Protein Losing Enteropathy, type (DIAR 10) approved 618183
Diarrhea 11, Malabsorptive, Congenital (DIAR11) approved 618662